Home/Filings/4/0001127602-18-008185
4//SEC Filing

Eaken Matthew John 4

Accession 0001127602-18-008185

CIK 0000094049other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:18 PM ET

Size

14.9 KB

Accession

0001127602-18-008185

Insider Transaction Report

Form 4
Period: 2018-02-21
Eaken Matthew John
VP & Interim CFO
Transactions
  • Award

    Common Stock

    2018-02-21$73.07/sh+94.211$6,8842,230.335 total(indirect: By Trust)
  • Award

    Stock Appreciation Right

    2018-02-21+2,5852,585 total
    Exercise: $72.99From: 2018-12-31Exp: 2028-02-20Common Stock (2,585 underlying)
  • Exercise/Conversion

    Common Stock

    2018-02-21+1,5474,358.278 total
  • Award

    Performance Shares

    2018-02-21+685685 total
    Common Stock (685 underlying)
  • Exercise/Conversion

    Performance Shares

    2018-02-218750 total
    Common Stock (875 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-02-21+862862 total
    Exercise: $72.99From: 2018-12-31Exp: 2028-02-20Common Stock (862 underlying)
Footnotes (4)
  • [F1]The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2017.
  • [F2]Vests ratably over three years beginning on the date shown.
  • [F3]Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020.
  • [F4]Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2017.

Issuer

STEPAN CO

CIK 0000094049

Entity typeother

Related Parties

1
  • filerCIK 0001726434

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:18 PM ET
Size
14.9 KB